Clinical Trial Update: Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study

View source ↗

Summary

An observational trial update assessing the safety and efficacy of Mobic Inj. (meloxicam) in patients with osteoarthritis or rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Mobic Inj. (meloxicam)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis, Arthritis, Rheumatoid | Status: COMPLETED